Clinical Trial Update: Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a PARP inhibitor in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PARP inhibitor

Snippet

Sponsor: Lisette Nixon | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN